Skip to main content
Erschienen in: Head and Neck Pathology 2/2023

27.10.2022 | Original Paper

A Survey of Human Papillomavirus and Epstein-Barr virus Immunohistochemical Status in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) 

verfasst von: Etrat Javadirad, Ali Mousavi Yekta, Roya Chegene Lorestani, Javad Azimivaghar

Erschienen in: Head and Neck Pathology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Head and neck cancers are among the most prevalent cancers in the body. The aim of this study was to evaluate the expression of P16 and Epstein-Barr virus/latent membrane protein (EBV/LMP1) markers by immunohistochemistry in patients with squamous cell carcinoma of the head and neck.

Methods

In this study, all tissue samples of head and neck biopsies from 75 patients with confirmed diagnosis of squamous cell carcinoma (HNSCC) during 2016 to 2018 who admitted to the pathology laboratory of Imam Khomeini Hospital, Iran were selected. Paraffin blocks which prepared from these tissue samples were obtained. The slides were prepared from all samples for routine Hematoxylin-Eosin and immunohistochemical staining to evaluate the expression of EBV/LMP1 and P16 markers in cancer cells.

Results

The mean age of patients was 63 years and most patients (85.3%) were male in 75 patients with HNSCC. There was a significant relationship between EBV/LMP1 biomarker expression and vascular invasion in patients (p < 0.05). There was no relationship between EBV/LMP1 biomarker expression and age, sex ,anatomical site of tumor and tumor differentiation of patients (p > 0.05). There was no relationship between P16 biomarker expression and age, sex, tumor differentiation, anatomical site of tumor and vascular invasion of patients (p > 0.05). There is a significant relationship between P16 biomarker and EBV/LMP1 biomarker staining (p < 0.05).

Conclusion

The level of P16 positive biomarker was high in patients with HNSCC. However, the EBV/LMP1 positive biomarker was moderate in patients. There was a relationship between EBV/LMP1 biomarker expression and vascular invasion in HNSCC patients, as well as between P16 biomarker and EBV/LMP1 biomarker staining.
Literatur
1.
Zurück zum Zitat Jou A, Hess J. Epidemiology and molecular biology of head and neck cancer. Oncology research and treatment 2017, 40, 328–332. Jou A, Hess J. Epidemiology and molecular biology of head and neck cancer. Oncology research and treatment 2017, 40, 328–332.
2.
Zurück zum Zitat Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J-WW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh J-WW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRefPubMed
3.
Zurück zum Zitat Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45.CrossRefPubMed Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132:1133–45.CrossRefPubMed
4.
Zurück zum Zitat Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol. 2011;23:633–41.CrossRefPubMed Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol. 2011;23:633–41.CrossRefPubMed
5.
Zurück zum Zitat Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779–86.PubMed Sankaranarayanan R, Masuyer E, Swaminathan R, Ferlay J, Whelan S. Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res. 1998;18:4779–86.PubMed
6.
Zurück zum Zitat Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology. 2015;89:125–36.CrossRefPubMed Pezzuto F, Buonaguro L, Caponigro F, Ionna F, Starita N, Annunziata C, Buonaguro FM, Tornesello ML. Update on head and neck cancer: current knowledge on epidemiology, risk factors, molecular features and novel therapies. Oncology. 2015;89:125–36.CrossRefPubMed
7.
Zurück zum Zitat Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Prev Biomarkers. 2005;14:467–75.CrossRef Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Prev Biomarkers. 2005;14:467–75.CrossRef
8.
Zurück zum Zitat Longnecker RM, Kieff E, Cohen JI. Epstein-barr virus. In: Fields Virology: Sixth Edition. Adis (ESP): Wolters Kluwer Health; 2013. p. 11959 p. Longnecker RM, Kieff E, Cohen JI. Epstein-barr virus. In: Fields Virology: Sixth Edition. Adis (ESP): Wolters Kluwer Health; 2013. p. 11959 p.
9.
10.
Zurück zum Zitat Broccolo F, Ciccarese G, Rossi A, Anselmi L, Drago F, Toniolo A. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in keratinizing versus non-keratinizing squamous cell carcinoma of the oropharynx. Infect agents cancer. 2018;13:1–5.CrossRef Broccolo F, Ciccarese G, Rossi A, Anselmi L, Drago F, Toniolo A. Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in keratinizing versus non-keratinizing squamous cell carcinoma of the oropharynx. Infect agents cancer. 2018;13:1–5.CrossRef
11.
Zurück zum Zitat Kieser A. Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1). Signal Transduction. 2007;7:20–33.CrossRef Kieser A. Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1). Signal Transduction. 2007;7:20–33.CrossRef
12.
Zurück zum Zitat Korcum AF, Ozyar E, Ayhan A. Epstein-Barr virus genes and nasopharyngeal cancer. Turk J Cancer. 2006;36:97–107. Korcum AF, Ozyar E, Ayhan A. Epstein-Barr virus genes and nasopharyngeal cancer. Turk J Cancer. 2006;36:97–107.
13.
Zurück zum Zitat Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 2012;30:2102.CrossRefPubMedPubMedCentral Gillison ML, Zhang Q, Jordan R, Xiao W, Westra WH, Trotti A, Spencer S, Harris J, Chung CH, Ang KK. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 2012;30:2102.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Eze N, Lo Y-C, Burtness B. Biomarker driven treatment of head and neck squamous cell cancer. Cancers of the head & neck. 2017;2:1–12.CrossRef Eze N, Lo Y-C, Burtness B. Biomarker driven treatment of head and neck squamous cell cancer. Cancers of the head & neck. 2017;2:1–12.CrossRef
15.
Zurück zum Zitat Borthakur P, Kataki K, Keppen C, Khamo V, Medhi S, Deka M. Expression of Epstein Barr Virus encoded EBNA1 and LMP1 oncoproteins in nasopharyngeal carcinomas from Northeast India. Asian Pac J Cancer Prev. 2016;17:3411–6.PubMed Borthakur P, Kataki K, Keppen C, Khamo V, Medhi S, Deka M. Expression of Epstein Barr Virus encoded EBNA1 and LMP1 oncoproteins in nasopharyngeal carcinomas from Northeast India. Asian Pac J Cancer Prev. 2016;17:3411–6.PubMed
16.
Zurück zum Zitat Aaro T, Jaana R, Reidar G, Kari S, Stina S. Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget. 2017;8:27328.CrossRefPubMedCentral Aaro T, Jaana R, Reidar G, Kari S, Stina S. Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget. 2017;8:27328.CrossRefPubMedCentral
17.
Zurück zum Zitat Heiduschka G, Grah A, Oberndorfer F, Seemann R, Kranz A, Kornek G, Wrba F, Thurnher D, Selzer E. Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab. Strahlenther Onkol. 2014;190:832–8.CrossRefPubMed Heiduschka G, Grah A, Oberndorfer F, Seemann R, Kranz A, Kornek G, Wrba F, Thurnher D, Selzer E. Significance of p16 expression in head and neck cancer patients treated with radiotherapy and cetuximab. Strahlenther Onkol. 2014;190:832–8.CrossRefPubMed
18.
Zurück zum Zitat Ralli M, Singh S, Yadav S, Sharma N, Verma R, Sen R. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. J Cancer Res Ther. 2016;12:232.CrossRefPubMed Ralli M, Singh S, Yadav S, Sharma N, Verma R, Sen R. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. J Cancer Res Ther. 2016;12:232.CrossRefPubMed
19.
Zurück zum Zitat Saito Y, Yoshida M, Ushiku T, Omura G, Ebihara Y, Shimono T, Fukayama M, Yamasoba T, Asakage T. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer. 2013;119:2005–11.CrossRefPubMed Saito Y, Yoshida M, Ushiku T, Omura G, Ebihara Y, Shimono T, Fukayama M, Yamasoba T, Asakage T. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer. 2013;119:2005–11.CrossRefPubMed
20.
Zurück zum Zitat Fernandes Q, Merhi M, Raza A, Inchakalody VP, Abdelouahab N, Zar Gul AR, Uddin S, Dermime S. Role of Epstein–Barr virus in the pathogenesis of head and neck cancers and its potential as an immunotherapeutic target. Front Oncol. 2018;8:257.CrossRefPubMedPubMedCentral Fernandes Q, Merhi M, Raza A, Inchakalody VP, Abdelouahab N, Zar Gul AR, Uddin S, Dermime S. Role of Epstein–Barr virus in the pathogenesis of head and neck cancers and its potential as an immunotherapeutic target. Front Oncol. 2018;8:257.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). In Proceedings of the Seminars in cancer biology, 2012; pp. 144–153. Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). In Proceedings of the Seminars in cancer biology, 2012; pp. 144–153.
22.
Zurück zum Zitat Young LS, Murray PG. Epstein–Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003;22:5108–21.CrossRefPubMed Young LS, Murray PG. Epstein–Barr virus and oncogenesis: from latent genes to tumours. Oncogene. 2003;22:5108–21.CrossRefPubMed
23.
Zurück zum Zitat Chew MM, Gan S-Y, Khoo AS, Tan E-L. Interleukins, laminin and Epstein-Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer. 2010;10:1–10.CrossRef Chew MM, Gan S-Y, Khoo AS, Tan E-L. Interleukins, laminin and Epstein-Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer. 2010;10:1–10.CrossRef
24.
Zurück zum Zitat Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI. Prognostic value of p16 expression in Epstein-Barr virus–positive nasopharyngeal carcinomas. Head Neck. 2016;38:E1459–66.CrossRefPubMed Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI. Prognostic value of p16 expression in Epstein-Barr virus–positive nasopharyngeal carcinomas. Head Neck. 2016;38:E1459–66.CrossRefPubMed
Metadaten
Titel
A Survey of Human Papillomavirus and Epstein-Barr virus Immunohistochemical Status in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC) 
verfasst von
Etrat Javadirad
Ali Mousavi Yekta
Roya Chegene Lorestani
Javad Azimivaghar
Publikationsdatum
27.10.2022
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2023
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-022-01483-0

Weitere Artikel der Ausgabe 2/2023

Head and Neck Pathology 2/2023 Zur Ausgabe

Neu im Fachgebiet Pathologie

Assistierter Suizid durch Infusion von Thiopental

Thiopental Originalie

Als Folge des Urteils des Bundesverfassungsgerichts zur Sterbehilfe im Jahr 2020 wurde in den Jahren 2021–2023 eine Reihe (n = 23) von assistierten Suiziden im Landesinstitut für gerichtliche und soziale Medizin Berlin mit jeweils identischen …

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …